It is possible that children finding it difficult to concentrate on simple tasks or finding it difficult to remember things from memory could be suffering from long COVID symptoms, as per a new study published in Lancet.
The latest study done at a national level in Denmark shows children aged 0-14 years who had suffered from SARS-CoV-2 infection had more prevalent long-lasting symptoms.
While children who had a history of SARS-CoV-2 infection in all age groups from 0 to 14 years reported a higher prevalence of long-lasting symptoms compared with age-sex-matched controls, and, among the oldest respondents, more females than males had long-lasting symptoms, the study found.
Symptoms of lung Covid in children
According to the study, the most common symptoms reported among children aged 0-3 years were mood swings, rashes, stomach aches, cough, and loss of appetite.
Among those aged 4-11 years, mood swings, trouble remembering or concentrating, and rashes were most common; and among those aged 12-14 years, fatigue, mood swings, and trouble remembering or concentrating were most common.
In cases aged 12-14 years, more girls than boys had at least one symptom lasting more than 2 months, the study said.
In this study of Danish children with a history of SARS-CoV-2 infection and age-sex-matched controls with no history of SARS-CoV-2 infection, it was found that cases in all age groups had higher odds of having long- lasting symptoms.
However, cases in the oldest age groups (4-11 and 12-14 years) had better quality-of-life scores. Additionally, cases had more sick days and more daycare or school absences than did controls within the past year.
Children at risk of Covid
Children worldwide are at risk of SARS-CoV-2 infection. This is because of a lack of approved vaccines for children aged 0-4 years, few countries recommend vaccination for children aged 5-11 years, low vaccine uptake among children overall, difficulties practicing physical distancing and, in particular, low vaccine effectiveness against the omicron variant of SARS-CoV-2.